Not applicableNot Yet RecruitingNCT07625514
What this trial is testing
24-Week Recurrence Rate of Gout Following Firsekibart Treatment
Who this might be right for
Gout Flare
Second Affiliated Hospital, Zhejiang University, School of Medicine 264
Showing 20 of 0 results